-65.8%
JOBY vs GSK
+14.9%
-80.7%
-71.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +4.1% | +5.0% | -0.9% | +4.3% |
| 7D | -0.6% | +4.9% | -5.5% | -0.5% |
| 30D | -12.6% | +9.9% | -22.5% | -12.3% |
| 3M | -36.6% | +0.2% | -36.8% | -36.5% |
| 6M | -43.0% | +2.3% | -45.3% | -43.1% |
| YTD | -61.7% | +7.1% | -68.8% | -61.6% |
| 1Y | -65.8% | +13.1% | -78.9% | -67.4% |
| All | -65.8% | +14.9% | -80.7% | -67.4% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling